Doxorubicin Hydrochloride Liposome Injection, Suspension, Liposomal
Product Images NDC 0338-0080

This is a description of a medication called DX3, specifically a liposomal formulation of DOXOrubicin Hydrochloride. It is meant for intravenous infusion only and is a cytotoxic substance. The medication comes in a single-dose vial containing 20mg in 10mL and should be refrigerated between 2-8°C. This product is manufactured for Baxter Healthcare Corporation with a registered trademark. Any unused portions should be discarded.*

This text seems to be a drug label or prescription information for a medicine called DOXOrubicin Hydrochloride liposome injection. It indicates that it should not be substituted for DOXOrubicin Hydrochloride and should only be used for intravenous infusion. The storage temperature is also mentioned, and it is mentioned that it is a cytotoxic drug. The text also includes a caution note regarding liposomal formulation and the dosage information should be consulted with package insert.*

DOXOrubicin Hydrochloride is a liposomal formulation of doxorubicin used in chemotherapy. It is manufactured by Baxter Healthcare Corporation in Taiwan and is not interchangeable with other forms of doxorubicin. The liposomes are composed of cholesterol, fully hydrogenated soy phosphatidylcholine, and N-(carbonylmethoxypolyethylene glycol 2000)-1,2-distearoyl-sn-glycero-3-phosphocholine sodium salt. The solution also contains ammonium sulfate, histidine, hydrochloric acid, sodium hydroxide, and sucrose. Each mL of DOXOrubicin Hydrochloride contains 2 mg doxorubicin Hydrochloride in stealth liposome carriers.*

DOXOrubicin Hydrochloride liposome injection is a single-dose vial containing 20 mg in 10 mL, intended for intravenous infusion. It is a cytotoxic drug that must be used only after dilution and refrigerated at 2-4°C. Unused portion must be discarded. The recommended dosage should be obtained from the prescribing information provided as it is a liposomal formulation.*

DOXOrubicin Hydrochloride is a form of liposomal formulation for injection that should not be substituted for other forms of Doxorubicin Hydrochloride. It is manufactured by Baxter Healthcare Corporation and each mL contains various ingredients such as cholesterol, soy phosphatidylcholine, MPEG-DSPE, and others. The injection may contain hydrochloric acid and sodium hydroxide to adjust the pH. It is important to note that the text contains errors which may affect the accuracy of the information.*

This is a description of a medication called "DOXOrubicin Hydrochloride liposome injection" which is a single-dose vial containing 50 mg in 25 mL with a concentration of 2 mg/mL. It is a cytotoxic drug that is suitable for intravenous infusion only and must be refrigerated at 2°-8°C. The medication is manufactured by the Baxter Healthcare Corporation and should not be substituted for other medications or formulas. The package insert provides more information on the recommended dosage.*

DOXOrubicin Hydrochloride liposome injection is a product of Taiean, and it is manufactured for Baxter Healthcare Corporation in Deerfeld, L 60015. The GTIN number for the product is 0030338086016. Each ml of the injection contains doxorubicin Hydrochloride, STEALTH liposome carriers, cholesterol, fully hydrogenated soy phosphaticylcholine (HSPC), and more. The product is not interchangeable with DOXORUBICIN Hydrochloride, and it has a unique formulation.*

This text appears to be a label of a medicine called "DOXOrubicin Hydrochloride liposome injection". It has a warning label not to be substituted for DOXORUBICIN Hydrochloride and should only be used after dilution. It also indicates that the medicine should be refrigerated and not frozen. The recommended dosage is advised to be seen from the prescribing information.*

DOXOrubicin Hydrochloride liposome injection is a medication manufactured by Baxter Healthcare Corporation, Deerfield. It is a liposomal formulation used for DOXORUBICIN Hydroch. Each mL contains doxorubicin Hydrochloride, 2 mg, STEALTH liposome carriers with a composition of cholesterol, 3.19 mg; fully hydrogenated soy phosphatidylcholine (HSPO), .58 mg, and N-(carbonylmethoxypolyethylene glycol 2000)-1, 2-distearoyl-sn-glycero-3-phosphoethanolamine sodium salt (MPEG-DSPE), 3.19 mg. The medication also contains certain additives like ammonium sulfate, histidine, hydrochloric acid or sodium hydroxide, and sucrose. The product is a registered trademark of Baxter International, Inc., or its subsidiaries.*